Abstract
This letter reports the synthesis and structure-activity relationship (SAR) study of a series of triazine dimers as novel antiviral agents. These compounds were obtained through a bivalent ligand approach in which two triazine moieties are covalently connected by suitable linkers. Several compounds showed submicromolar activity against wild-type HIV-1 and moderate activity against single mutant strains.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Line
-
Dimerization
-
HIV Reverse Transcriptase / antagonists & inhibitors
-
HIV Reverse Transcriptase / metabolism
-
HIV-1 / drug effects
-
HIV-1 / enzymology
-
Humans
-
Reverse Transcriptase Inhibitors / chemical synthesis*
-
Reverse Transcriptase Inhibitors / chemistry*
-
Reverse Transcriptase Inhibitors / pharmacology
-
Structure-Activity Relationship
-
Triazines / chemical synthesis
-
Triazines / chemistry*
-
Triazines / pharmacology
Substances
-
Reverse Transcriptase Inhibitors
-
Triazines
-
HIV Reverse Transcriptase